Knowledge translation may be particularly challenging in pediatric rehabilitation, where study findings are often ambiguous owing to low statistical power or inconsistent responses to intervention. Disconnection between research protocols and clinical practicality, as well as variability of responsiveness in heterogeneous pediatric populations, may further impede integration of research findings into everyday practice. Use of single-subject research designs (SSRDs) may bridge the gap between research and practice, with robust design options that better identify and preserve patterns of responsiveness to specific interventions and offer protocols that are more readily implemented in practice settings than can be done in traditional randomized controlled trials. This review defines SSRD, provides examples of research questions that can be answered using SSRD, details the experimental designs that can be used and the level of evidence of each design, and describes statistical analysis approaches and clinical application. This analysis will aid researchers, reviewers, clinicians, and others in better understanding SSRD methodology and its application in everyday practice.
Single-subject research designs (SSRDs) provide a bridge between research and practice by helping to preserve the individual variability of responses to intervention. SSRDs assist service providers more directly in their decision-making process than is possible with more traditional group design research. These designs may be especially useful in pediatric rehabilitation, where research-based evidence is often ranked at low levels on traditional evidence scales or results are too vague, short-lived, or specific to be easily translated to clinical practice.
Knowledge translation is a widely debated and baffling topic in contemporary healthcare literature. The knowledge translation movement is focused on two-way communication between researchers and service providers, with the dual intent of moving research-based discoveries into everyday practice and allowing practice to inform research questions. Currently, the average research time-lag between discovery and clinical implementation is estimated to be 10 to 20 years. 1 In pediatric rehabilitation, as in other healthcare arenas, the gap between what is known about best practice and the realities of what actually occurs every day in clinical or educational settings persists, despite a positive attitude on the part of providers toward evidence-based practice. 1 Reports on barriers to knowledge translation have traditionally focused on the provider side of the equation and include situational factors such as decreased productivity ratios due to time spent in non-patient care activities, confidence in one's own ability to interpret research-based evidence, access to resources, and costs of such access.
Research practices contribute to the translational gap with a high volume of evidence that provides basic scientific or pre-clinical foundation not easily translated to clinical practice. Measurement methods or intervention protocols are often too complex or expensive to be clinically pragmatic. 2, 3 Translation may be even more challenging in pediatric rehabilitation, where the literature is generally less robust, with many if not most reports lacking the power to reveal a statistically significant result. These limitations make the process of understanding and applying evidence-based decision-making even more confusing.
One solution to this problem is the use of SSRD methodology, which is considered by some to be the highest level of evidence for clinical decision-making. 4 Results of traditional group design in pediatric research can seem ambiguous in instances where participant responses are inconsistent, resulting in null findings even though some individuals have shown improvement while others have shown decline. Single-subject methodology preserves and describes the variability of responses within and between individuals, which can be very useful in the heterogeneous populations often studied in pediatric rehabilitation. 5 The conventional means of reporting SSRD results with detailed information about participant characteristics and visual graphic analysis may also facilitate clinical comparisons and allow clinicians to predict whether their patient will respond to intervention in a manner similar to that of the study participants. 6 Moreover SSRD, a form of patient-oriented research, occurs within the clinical world rather than the research laboratory, providing patients and clinicians with an opportunity to contribute directly to research and advancing the process of knowledge translation. 5 SSRDs are methodologically robust, offering a variety of designs to fit many practice-related research questions. Contemporary SSRD reports frequently use statistical methods specific to this design, and meta-analyses are becoming more frequent. [7] [8] [9] Pairing these methods with traditional SSRD visual analysis methods may provide greater clarity and applicability of research findings. 10 Because SSRD is more likely to occur in clinical settings and involve frequent measurement, the likelihood that measures and interventions will be clinically pragmatic is also increased.
Despite the rigor and utility of SSRD, this experimental method is underused, particularly in the context of a medically oriented rating system for evidence in which large-scale, randomized clinical trials and homogenous systematic reviews of randomized clinical trials serve as the criterion standard for levels of evidence. 11 While these designs have high internal validity, they also have drawbacks in terms of knowledge translation, including their high costs, stringent laboratory-control, and narrowly defined questions. These characteristics may actually distance such studies from the messy complexities of clinical problems. 12 Considering the clinical applicability of SSRD and the need for evidence that can be readily implemented into clinical and educational practices, particularly in pediatrics, it is important for researchers, providers, and other stakeholders to better understand SSRD and its potential role in knowledge translation.
The purposes of this review are: (1) to help providers, manuscript reviewers, and other stakeholders interpret SSRD findings and apply them in the course of knowledge translation; and (2) to provide information useful to researchers as they consider the best designs for answering their own research questions, particularly when resources are limited or responses are likely to be diluted by group design methods. We will define SSRD, compare SSRD with other methodologies, identify the research questions that can be answered using SSRD, illustrate the methodologies available to answer these questions, demonstrate the analysis and interpretation of SSRD findings, discuss usefulness of meta-analysis in SSRD, review methods of generalization, and consider the clinical significance of SSRD compared with the statistical significance of group designs.
COMPARISON OF SSRD WITH GROUP RESEARCH DESIGNS, CASE STUDIES, AND OTHER METHODOLOGIES
Single-subject research design may also be known as single-case design, single-time series study, or N-of-1 studies, depending on the specifics of the research. This methodology seeks to answer questions about the effects of an independent variable on an outcome of interest using systematic measurement strategies. 13 All of these factors are identified ahead of time in SSRD and other research endeavors. SSRDs involve a unique and rigorous set of basic conventions that improve the robustness of SSRD studies, and help differentiate it from case studies and pilot studies (see Table SI , online supporting information).
One of the elements that distinguishes SSRD from group designs and other types of evidence is the establishment of distinct time-based phases. These phases allow patients and participants to serve as their own controls by reflecting each individual's pattern of the behavior of interest at baseline before the intervention is introduced, then with intervention at a minimum. The letter A is always used as the label for the baseline phase in coding and graphing SSRD. The baseline concept is essential to this methodology as it provides a basis of comparison for any intervention. The usual convention is to have at least three points of consistent measurement to establish a baseline. If that is not feasible, a trend can be established and the outcome measured for effects that differ from the initial trend. Intervention phases that follow the baseline phase are labeled in alphabetical sequences beginning with B by convention. So the first intervention introduced would be the B phase, and introduction of additional intervention phases would be labeled C, D, and so on. It is important for researchers to identify their designs using both the conventional labeling methods with a brief descriptor, for example multiple baseline AB design. Doing so will help researchers stick with their intended design throughout the study and will allow consumers or evaluators of research to more easily recognize what is happening. It should be noted here that when the approach to intervention does not vary, but the dosing or another aspect of the intervention has been modified, the different treatment phases may be denoted by B 0 , B″, and so on. Ideally, SSRD designs are replicated a minimum of three times across different behaviors, different individuals, or different tasks or environmental conditions.
Another important characteristic of high-quality SSRD is that all elements of the study should have clearly outlined operational definitions for all study components. This includes the study design itself, interventions or other independent variables of interest, target behaviors, outcomes, or other dependent variables to be measured. Meeting this requirement enhances fidelity to the design during study implementation and the reliability of measurement, without which study validity is absent.
The final common feature that should be present in all SSRDs is the graphic representation of results in a manner that clearly identifies the study phase and the measurement points taken for each individual within each phase. Phases are traditionally separated by a vertical line within a single graph, while replications across individuals, experimental conditions, or behaviors are represented in separate graphs.
What this paper adds
• Single-subject research designs (SSRDs) preserve variability of individual responses to care, with designs and levels of evidence relative to robustness of experimental control and quality of implementation.
SSRD should not be confused with case reports. Case reports describe what happened during the course of clinical care for a specific patient or group of patients, and are useful in illustrating new, interesting, well-documented diagnoses or interventions. Methods used during the course of care being reported on may or may not be shaped, the question to be answered may not be identified before the intervention, and the desire to limit the influence of confounding variables is probably not present. As a result, cause-and-effect conclusions cannot be drawn from case reports as there are no efforts to control threats to validity or to generalize results.
Single-subject research is also not the same as a small group design research or pilot study. Methods used in traditional group designs and SSRD are very different. SSRD is sometimes touted as a way of exploring a specific approach to practice, to see whether it might show enough promise to justify a larger group design study. Although this is possible, SSRD should be considered a stand-alone methodology that may not be appropriate if used in this way.
Careful experimental design is an important aspect of SSRD, which includes well-defined independent and dependent variables implemented consistently across individuals or conditions. In SSRD, each individual generally acts as his or her own control.
14 Systematic and frequent outcome measurement protocols are part of SSRD and allow patterns within individuals across varying conditions to be tracked and preserved, rather than amalgamating them into an 'average' response as occurs in group design research. Additional details about SSRD methodology and specific design follow.
RESEARCH QUESTIONS COMPATIBLE WITH SSRD METHODOLOGY
The research question being asked should drive the design and methods used in any research study. Thus, the first consideration in creating, interpreting, or evaluating SSRD is whether SSRD methodology is/was an appropriate fit for the research question being answered. While it is plausible that imaginative researchers could apply the principles of SSRD to a wide variety of research scenarios, there are specific types of question for which SSRD is particularly well suited. Single-subject designs are best used when there are at least two levels of the independent variable and when outcomes can be measured quantitatively. Questions that are best answered by qualitative methods or when there is only one level of the independent variable are not a good fit for SSRD.
The quintessential question that can best be answered by SSRD involves response to intervention or other change of condition: are changes in the independent variable (the characteristic or intervention of choice) associated with measurable change in the outcome of interest (dependent variable)? The answers to this type of question may provide evidence that can be easily translated to clinical practice when patient populations, interventions, and outcomes line up well to answer PICO (patient problem or population, intervention, comparison and outcome) or other foreground-model queries posed by evidence-based practitioners. 15 Table SII (online supporting information) provides examples of research questions appropriately investigated by SSRD methods. Please note that causality is not implied here as it is associated with the strength of the specific design used and the quality with which the research is done. 16 
SPECIFIC SINGLE-SUBJECT EXPERIMENTAL DESIGNS
Once it has been decided that the question can be appropriately answered by SSRD methodologies, the next step is to match the question, resources, and other relevant factors with specific design options for conduct of SSRD studies. The key to successful SSRD is that the research question drives the choice of design, boosting the internal validity of the study in the presence of reliability. The simplest design is AB, which includes a baseline phase (A) and a single intervention phase (B). This design may suggest a relationship between the intervention and behavioral pattern changes away from baseline phase seen during the intervention phase. However, much like a pretest-posttest group design study, AB designs lack the rigor to establish causality, and may not provide enough experimental control to definitively answer many research questions.
Withdrawal designs are studies that involve at least one return to a baseline phase following at least one intervention phase. Studies that end on the withdrawal phase are typically labeled ABA, while studies that end on a second intervention phase are labeled ABAB. Such methods are appropriate for answering questions about dose-response: questions about the effects of medications expected to be most effective during the intervention phase (B) and which fade after dosing has stopped. These designs are also helpful in examining whether true learning has occurred as when the question involves sustainability of effects of intervention after the conclusion of an episode of care. There are potential ethical concerns in withdrawing an effective treatment before a target outcome has been reached, especially when the study ends on a withdrawal phase as occurs in ABA studies. An example of a study that used an ABA design may be found in the investigation by Pool et al. 17 of use of the walk aide device to provide functional electrical stimulation to children with unilateral cerebral palsy. In this study, 12 participants each had a 6-week baseline phase, followed by 8 weeks of using the device, then another period in which the device was withdrawn, demonstrating that the changes occurring during the intervention phase were maintained after the treatment period had ended.
Multiple-baseline designs (MBDs) involve more than one participant, setting, or task condition delivered for different periods during the study. For example, in a 12-week multiple baseline intervention study, each of three participants may be assigned to have a 4-, 6-, or 8-week baseline phase, with the remainder of the study spent in the intervention phase. This design increases the likelihood that any changes occurring during the intervention phase are actually related to the treatment itself, since the timing of events is different for each individual or condition. Multiple baseline SSRD may be further strengthened when random assignment of individuals to length of baseline phase or differing experimental conditions is incorporated into the study design. Multiple baselines may also allow for recording different types of change seen as intervention progresses. These designs typically do not involve withdrawal of the intervention. Instead, the argument for causative relationships is strengthened when changes consistently occur with the introduction of the intervention, regardless of when it was introduced or the experimental conditions under which it was introduced. One of the downsides of using MBD designs is that some individuals may have longer baseline periods than others, which may not be well tolerated by children or families who become impatient to begin the intervention phase. An example of a multiple-baseline design may be found in the work by Butler on powered mobility in young children. 18 The design of this seminal work allowed the author to thoroughly examine the changes in behavior engendered by the introduction of powered mobility. In a group design, the changes in behavior would have been lost.
Changing criterion designs (ABCD. . .) look for specific changes in target behaviors or desired outcomes as the intervention strategy changes. These designs are appropriate when used with outcomes that are expected to change gradually over time and require either incentives or consequences to ensure adherence throughout the course of the study. The added or subtracted incentives or consequences are examples of how interventions can vary across phases. These designs may also be useful in answering questions investigating comparative effectiveness of different intervention or dosing strategies. Random assignment of individuals to specific strategies or the order in which the interventions are introduced is not typically part of the changing criterion design. McDaniel and Bruhn used a changing criterion design in their study of a behavioral intervention strategy for seventh graders with a history of problem behaviors, in which the 'check in/check out' intervention strategy was modified as children in the study met predetermined benchmarks of behavioral change. 19 Alternating treatments designs evaluate a single outcome with several interventions. These designs may include random assignment, but the design must include withdrawal before introduction of each new intervention (e.g. ABAACA) to allow for a washout or stabilization period between various intervention phases. This design may be extended to include multiple treatments and outcomes, but doing so may pose a threat to validity when effects spread across multiple outcomes. Obrusnikova and Bibik used an alternating treatments design to compare the effects of a canine companion with that of a child peer on the physical activity levels of children with autism spectrum disorder, demonstrating a stronger effect whenever the canine was introduced, regardless of the order in which the two conditions were implemented. 20 Use of multiple intervention phases delivered concurrently (ABCA) may be used to study effectiveness of interventions, but the pairing of interventions should be clinically plausible. This design is most useful when the interventions are complementary and appropriate for withdrawal. These designs may contain and are strengthened by elements of random assignment. In summary, the hallmarks of good SSRD designs include: (1) baselines exhibiting stability or clear trends over multiple observations; (2) interventions, experimental conditions, and target behaviors/outcomes accompanied by clear operational definitions; and (3) results reported using clear and convincing graphs that reflect the design and the results. Choices for use of specific designs should be well matched to the research question(s) being investigated. Several designs allow for changing or adding interventions and measuring multiple outcomes, which reflect the reality of our patients' lives. Other designs allow for random assignment to experimental conditions that minimize threats to internal validity and give us confidence to apply the results. Any design may be replicated to enhance generalizability.
SSRD LEVELS OF EVIDENCE
These methods have been organized into levels of evidence in a manner that parallels that used to evaluate group design research. The levels assigned to a study reflect the rigor and credibility of the study to establish causality and control threats to validity. For SSRD, the levels are based largely on the opportunity for random assignment of study participants to study conditions and generalizability of findings. The levels for ranking SSRD described here are from the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) Methodology for Systematic Reviews. 16 In addition, quality-rating questions have been developed specifically for SSRD, which allow the reader to judge the rigor of the methodology used to execute the study design. 16 Level V designs include non-randomized controlled AB (two phases) single-subject research with clear-cut results. Findings are generalizable if replicated across three or more different participants. Level V studies suggest causal inferences allowing for testing of ideas.
Level IV designs include non-randomized, controlled SSRDs with at least three phases (ABA, ABAB, BAB, etc.) with clear-cut results. Findings are generalizable if replicated across three or more different participants. Level IV studies can only hint at causal inferences.
Level III study designs include non-randomized, nonconcurrent, controlled MBD with clear-cut results. This design requires multiple participants beginning the treatment at different times. The essential point is that the studies are non-randomized and non-concurrent, thus allowing for great threats to validity. Findings are generalizable if they are replicated across a minimum of three participants, behaviors, or settings. Level III studies may provide limited causal inferences.
Level II study designs include non-randomized, controlled, concurrent MBDs with clear-cut results. Findings are generalizable if design consists of a minimum of three participants, behaviors, or settings. Level II designs can provide limited causal inferences.
Level I study designs include randomized controlled Nof-1 (randomized clinical trial) as well as alternating treatments designs and MBDs meeting specific conditions. When alternating treatments designs are replicated across three or more participants, they may rise to level 1. When all participants are run concurrently, or a non-concurrent study shows clear-cut results, or the MBD design is replicated across a minimum of three participants, behaviors, or settings, then MBDs may also rise to level I; however, the element of randomization must be present. Level I designs provide generalizable findings and causal inferences (Table SIII, online supporting information).
Among the most common concerns about validity of SSRD (and other designs involving interventions) is the possibility of carry-over effects when multiple interventions or doses have been studied. The SSRD levels of evidence described here have been tested for reliability and validity (Romeiser Logan L, Romeiser JL, Vogtle LK, et al., personal communication 2016), both of which were found to be at acceptable levels after some revisions to the original questions. Thus, using the scale allows those who design, engage in, review, or apply SSRD to have greater confidence that threats such as carry-over effects are better controlled in studies that approach level I than in studies with a lower rating on the scale. Strategies such as randomization of the order in which multiple interventions across participants or conditions are introduced, or the introduction of multiple baselines, represent higher levels of evidence precisely because they offer a means of controlling such threats. In addition, one specific strategy that may be used to minimize carry-over effects includes use of a wash-out period, as would occur in a return to baseline phase (e.g. ABA or ABAC designs). 21 Another strategy that may limit or help identify carry-over effects would be to reverse the order in which intervention and baseline phases are introduced (e.g. ABBA) to the study to examine whether the sequence itself may influence outcome. In many instances in pediatric rehabilitation studies, carryover effects are desirable and indicative of more permanent learning, including a withdrawal phase that would allow follow-up to document sustainability of changes over time, even after the intervention has been withdrawn. In this instance, ending on an A or baseline phase would help to demonstrate the effectiveness of the intervention in bringing about permanent change. Other strategies for teasing out effects of interventions that involve approaches to analyzing results are discussed in the next section.
ANALYSIS OF STATISTICAL AND CLINICAL SIGNIFICANCE IN SSRD
The first line of analysis for SSRD is visual inspection of time-series graphs that clearly reflect the design and data collected. Graphs must be carefully constructed and clearly defined. However, this method may be subject to a type I error (finding change when none is present). Statistical methods are growing in popularity but typical inferential statistical methods are considered suspect in SSRD because the data rely on repeated measurements of the same subject. Time-series approaches to statistical comparison may be more appropriate. 22 Two statistical programs (SSD for R and SINGWIN [https://www.ssdanalysis.com/]) have been designed specifically for SSRD.
Determination of clinical significance of findings in SSRD may be approached in several ways. Effect size is rarely determined in SSRD, but it is critical for researchers and readers to decide whether use of a particular intervention results in meaningful change for the children and families involved. At minimum, the reader will want to note the percentage of non-overlapping data points between the baseline and the intervention. Researchers can assist readers by providing this information. At maximum, regression analyses may be applied to baseline and intervention data to detect treatment effect size. One choice is to calculate a standard mean difference by subtracting the intervention average from the baseline and dividing by the standard deviation of the baseline. 23 Alternatively, researchers and consumers may compare the amount of change with published standard errors, minimal detectable differences, or minimal clinically important differences where they exist for specific measurement tools. A third alternative with increasing popularity is to include self-reports of global ratings of change as an additional outcome measure for studies of intervention effectiveness. Pediatric versions of global ratings of change scales have been used in pediatric research and may be helpful in SSRD (See Figure 1 for section summary.). 24 
COMBINING SSRD STUDIES FOR META-ANALYSIS
Single-subject studies may be combined if similar interventions and outcomes have been studied. The statistical analyses of these data continue to be somewhat controversial, with many suggestions in the literature of ways to combine SSRD data (Fig. 1) . 9, 25 The advantage of combining data in this way is that identifying trends that occur across studies strengthens the arguments for causality and generalizability beyond that of an individual SSRD study.
GENERALIZATION AND APPLICATION OF SSRD RESULTS
Replication of SSRD studies allows the reader to have greater confidence in results when they are consistent across participants, behaviors, or conditions. One must remember that these studies control conditions and interventions very closely, so the results are most applicable when the subject conditions and behavioral measures being considered are similar to those used in the study.
It is important that authors of SSRDs report participant characteristics with sufficient detail to allow readers of SSRD to determine whether or not the interventions studied are likely to be effective with their patients on an individual basis. Further, where results across participants are inconsistent, it is important for authors to highlight differences in participant characteristics that may serve as covariates that help to determine who is more or less likely to benefit from specific intervention strategies. 26 Specific details of analytical strategies that facilitate statistical testing for covariates is beyond the scope of this paper and may be found in the related scientific literature.
SUMMARY
Although service providers across professional disciplines generally agree that research-based evidence should be an important component in their clinical decision-making, there is a substantial lag between the time research findings are reported and when the related practices become integrated into everyday use. In pediatric rehabilitation, variability of magnitude and direction of response in the heterogeneous sample populations of children with complex disorders such as autism spectrum disorder or cerebral palsy may mask results and further delay knowledge translation. Use of SSRDs has been identified as a possible means of bridging this gap by providing evidence that may be more immediately applicable to clinical practice, and gives service providers a way of participating in the research process that use of traditional group designs may not. Single-subject research methods offer control through systematic measurement and implementation, often under conditions that reflect the complexity and practicality of everyday practice. Thus, if a reader of research reviews an SSRD report, judges the study design to be an appropriate match for the question being asked, and finds that it was conducted in a reliable manner consistent with the design specified, the reader can be certain that this intervention worked for this individual/patient under these conditions. Determination of cause-and-effect relationships is reflected in SSRD levels of evidence and rests on multiple factors including study design, establishment of baseline trends before intervention, replication across participants, conditions, and behaviors, and use of random assignment of participants. Determination of statistical significance in
Meta-analysis
• Combines >1 SSRD study mathematically
• Studies may only be combined when sample populations, independent variables, e.g. interventions, and behaviors/outcomes are homogenous across studies
• Strengthens arguments for causality and generalizability over individual SSRDs SSRD reports is dependent upon the approach to analysis, whether trends are replicated across conditions, behaviors, or participants, and the appropriate use of visual and inferential approaches to analysis. Determination of clinical significance in SSRD requires a proxy for effect size that reflects whether the change that occurred is actually meaningful for the children and families involved in each study. Application of the SSRD levels of evidence reviewed here may help researchers improve their methodology, and assist reviewers and clinicians in interpreting reports of findings and understanding the level of trust they can have in reports of SSRD research.
